background
role
pathogenesi
airway
infl
ammatori
diseas
remain
elus
therefor
studi
concentr
sputum
plasma
patient
copd
patient
pulmonari
tb
ptb
investig
mechanismofact
effect
bronchial
epitheli
cell
vitro
method
human
bronchial
epitheli
cell
grown
airliquid
interfac
cultur
activ
alon
combin
infl
ammatori
cytokin
presenc
absenc
variou
signal
molecul
inhibitor
express
detect
revers
transcript
polymeras
chain
reaction
enzymelink
immunosorb
assay
elisa
underli
signal
pathway
studi
intracellular
stain
use
fl
ow
cytometri
western
blot
elisa
sirna
result
signifi
cantli
higher
sputum
plasma
concentr
found
patient
copd
n
p
p
respect
patient
ptb
n
p
p
respect
healthi
control
subject
n
sputum
plasma
level
patient
copd
correl
neg
fev
r
p
sputum
plasma
patient
ptb
correl
posit
mycobacteri
load
sputum
r
p
vitro
studi
demonstr
could
induc
gene
protein
express
bronchial
epitheli
cell
regul
activ
phosphatidylinositol
kinas
akt
signal
pathway
conclus
product
relat
pathogenesi
copd
ptb
induc
express
bronchial
epitheli
cell
activ
signal
pathway
chest
abbrevi
elisa
enzymelink
immunosorb
assay
ifn
interferon
pbec
primari
human
bronchial
epitheli
cell
phosphatidylinositol
kinas
ptb
pulmonari
tb
th
helper
tnf
tumor
necrosi
factor
b
ronchial
epitheli
cell
activ
involv
initi
maintain
regul
innat
adapt
immun
respons
airway
activ
bronchial
epitheli
cell
produc
varieti
infl
ammatori
mediat
serv
paracrin
autocrin
manner
regul
airway
infl
ammat
pleiotrop
cytokin
consist
subunit
earli
product
activ
antigenpres
cell
stimul
tolllik
receptor
ligand
infecti
agent
could
drive
differenti
helper
th
cell
type
subset
earli
stage
develop
support
germin
center
function
enhanc
product
function
follicular
th
cell
abl
stimul
monocyt
mast
cell
keratinocyt
produc
varieti
proinfl
ammatori
cytokin
addit
exhibit
antitumor
activ
promot
effector
respons
cell
natur
killer
cell
hand
play
immunoregulatori
role
suppress
develop
approv
inform
consent
obtain
particip
accord
declar
helsinki
sputum
induc
taken
accord
protocol
describ
previous
ethylenediaminetetraacet
acid
venou
peripher
blood
also
collect
obtain
plasma
sputum
plasma
store
analysi
durat
time
sputum
plasma
sampl
protein
analysi
patient
sampl
month
recombin
human
b
interferon
ifn
g
tumor
necrosi
factor
tnf
purchas
r
system
inhibitor
k
ba
phosphoryl
inhibitor
extracellular
signalregul
kinas
inhibitor
cjun
ntermin
kinas
inhibitor
mitogenactiv
protein
kinas
inhibitor
phosphatidylinositol
kinas
inhibitor
janu
kinas
inhibitor
purchas
calbiochem
corp
g
inhibitor
inhibitor
purchas
merck
bioscienc
studi
concentr
dimethyl
sulfoxid
volvol
primari
human
bronchial
epitheli
cell
pbec
purchas
sciencel
research
laboratori
cultur
bronchial
epitheli
cell
growth
medium
describ
previous
cell
obtain
american
type
cultur
collect
use
instead
pbec
effi
cient
transfect
sequenc
pcr
primer
describ
tabl
level
gene
express
quantifi
ed
calcul
ratio
densitometr
read
band
intens
complementari
dna
sampl
concentr
ifng
quantit
enzymelink
immunosorb
assay
elisa
reagent
r
system
level
supernat
cell
lysat
quantit
commerci
avail
elisa
kit
biosourc
accord
manufactur
instruct
express
amount
recov
per
cell
activ
also
detect
use
elisa
kit
echelon
bioscienc
fl
ow
cytometr
analysi
permeabil
pbec
stain
mous
antihuman
phosphoryl
akt
bd
pharmingen
phosphoryl
cell
signal
technolog
mous
antibodi
bd
pharmingen
follow
fl
uorescein
isothiocyan
conjug
goat
antimous
secondari
antibodi
express
intracellular
phosphoryl
signal
molecul
analyz
flow
cytometri
facscalibur
bd
bioscienc
western
blot
analysi
activ
signal
molecul
perform
describ
previous
knockdown
gene
express
sirna
b
akt
control
sirna
purchas
cell
signal
technolog
cell
cell
subset
drive
expans
induc
regulatori
cell
produc
antiinfl
ammatori
cytokin
infl
ammatori
cell
macrophag
dendrit
cell
repres
highli
activ
cell
increas
airway
patient
infl
ammatori
diseas
copd
pulmonari
tb
ptb
activ
macrophag
dendrit
cell
main
sourc
might
aberr
product
patient
copd
ptb
howev
immunopatholog
role
airway
infl
ammat
relationship
airway
infl
ammatori
diseas
yet
elucid
aim
studi
investig
product
sputum
plasma
obtain
patient
copd
patient
ptb
studi
activ
human
bronchial
epitheli
cell
airway
infl
ammatori
diseas
patient
healthi
smoke
nonsmok
control
subject
enrol
studi
patient
copd
diagnos
use
criteria
gold
global
initi
chronic
obstruct
lung
diseas
patient
copd
exacerb
month
prior
visit
exclud
patient
copd
use
corticosteroid
theophyllin
longact
b
agonist
leukotrien
antagonist
antihistamin
within
month
prior
studi
exclud
subject
histori
respiratori
tract
infect
within
previou
month
patient
ptb
present
clinic
manifest
typic
mycobacterium
tuberculosi
includ
radiolog
analysi
sputum
smear
cultur
posit
confi
rmed
bacteriolog
examin
patient
ptb
newli
diagnos
patient
treat
antiinfl
ammatori
drug
nonsteroid
antiinfl
ammatori
drug
steroid
other
protocol
medic
copd
inhal
corticosteroid
patient
longact
muscarin
antagonist
patient
longact
b
agonist
patient
patient
copd
receiv
system
corticosteroid
therapi
newli
diagnos
patient
ptb
treat
standard
shortcours
antitb
chemotherapi
consist
isoniazid
rifampin
pyrazinamid
ethambutol
compar
healthi
nonsmok
smoker
normal
lung
function
sputum
significantli
elev
patient
copd
p
patient
ptb
p
fig
addit
level
plasma
patient
copd
patient
ptb
signifi
cantli
elev
compar
healthi
nonsmok
p
healthi
smoker
p
fig
howev
signifi
cant
correl
sputum
plasma
level
patient
copd
ptb
data
shown
five
patient
copd
six
patient
ptb
recruit
treatment
week
sputum
concentr
show
reproduc
percentag
chang
valu
patient
copd
fig
howev
sputum
level
decreas
six
patient
ptb
week
percentag
chang
level
fig
level
plasma
show
kinet
similar
observ
sputum
data
shown
sputum
concentr
patient
copd
neg
correl
fev
predict
r
p
fig
howev
correl
residu
volumetot
lung
capac
r
fig
signifi
cant
correl
forward
revers
forward
revers
amplifi
cation
reaction
perform
cycl
denatur
anneal
extens
data
express
mean
sd
differ
group
assess
kruskalw
test
mannwhitney
u
test
student
test
oneway
analysi
varianc
bonferroni
post
hoc
test
nonparametr
spearman
rank
correl
coeffi
cient
use
test
correl
two
paramet
p
consid
signifi
cantli
differ
total
subject
smoker
copd
nonsmok
ptb
healthi
smoker
healthi
nonsmok
recruit
studi
clinic
characterist
subject
summar
tabl
concomit
fig
howev
could
induc
express
tnfa
pbec
data
shown
shown
figur
stimul
pbec
fi
cytokin
ifng
b
tnfa
induc
product
howev
famili
cytokin
includ
could
activ
pbec
express
furthermor
combin
four
cytokin
ifng
b
tnfa
significantli
augment
product
comparison
observ
pbec
activ
cytotox
signal
molecul
inhibitor
pbec
determin
bromid
detect
sputum
sputum
patient
copd
r
data
shown
addit
plasma
correl
clinic
indic
smoke
statu
lung
function
test
data
shown
patient
ptb
posit
correl
observ
sputum
level
mycobacteri
load
assess
log
cfu
induc
sputum
r
p
fig
howev
detect
correl
plasma
level
mycobacteri
load
induc
sputum
r
data
shown
addit
signifi
cant
correl
detect
sputum
level
sputum
ifng
r
data
shown
shown
figur
could
induc
gene
express
pbec
time
depend
dose
depend
addit
protein
level
cell
lysat
signifi
cantli
increas
peak
time
point
stimul
ngml
fig
wherea
level
supernat
peak
could
induc
phosphoryl
fig
akt
fig
intracellular
fl
uoresc
stain
use
fl
ow
cytometri
activ
highli
reproduc
detect
pbec
respons
mean
elisa
western
blot
analys
fig
b
sirnaakt
suppress
express
cell
transfect
sirna
specifi
c
b
akt
western
blot
analysi
show
express
b
complet
inhibit
b
specifi
c
sirna
respect
fig
addit
phosphoryl
akt
signifi
cantli
reduc
knockdown
b
fig
shown
figur
induct
gene
protein
express
signifi
cantli
inhibit
cell
transfect
sirna
b
akt
studi
demonstr
fi
rst
time
sputum
plasma
level
signifi
cantli
elev
copd
ptb
patient
compar
assay
data
shown
specifi
citi
inhibitor
signal
pathway
investig
larg
use
differ
cell
type
includ
pbec
follow
previou
studi
toxic
threshold
valu
bromid
assay
select
optim
concentr
janu
kinas
inhibitor
nfk
b
inhibitor
inhibitor
extracellular
signalregul
kinas
inhibitor
mitogenactiv
protein
kinas
inhibitor
cjun
ntermin
kinas
inhibitor
signifi
cant
inhibitori
effect
without
cell
toxic
shown
figur
could
signifi
cantli
suppress
product
pbec
wherea
treatment
affect
releas
avoid
nonspecifi
c
effect
concentr
lower
concentr
compound
use
shown
figur
could
also
signifi
cantli
downregul
product
even
concentr
product
reduc
although
reach
statist
signifi
canc
howev
select
inhibit
g
effect
releas
fig
enhanc
express
intercellular
adhes
molecul
surfac
bronchial
epitheli
cell
took
bronchial
epitheli
cell
vitro
cell
model
studi
potenti
role
induct
cytokin
chemokin
bronchial
epitheli
cell
found
abl
induc
express
tnfa
consist
previou
report
could
stimul
product
monocyt
keratinocyt
fi
broblastlik
synoviocyt
fact
pivot
chemokin
contribut
airway
infl
ammat
signifi
cantli
increas
product
seen
airway
infl
ammatori
diseas
copd
ptb
chronic
bronchiti
sever
acut
respiratori
syndrom
studi
found
novel
induc
healthi
control
subject
addit
sputum
plasma
concentr
copd
show
signific
correl
fev
suggest
possibl
link
diseas
sever
howev
sputum
correl
residu
volumetot
lung
capac
indic
may
associ
alveolar
wall
destruct
copd
addit
sputum
plasma
correl
mycobacteri
load
sputum
patient
ptb
suggest
sputum
may
refl
ect
intens
tb
infect
addit
copd
ptb
patient
current
recruit
evalu
sputum
plasma
convers
respons
antiinfl
ammat
therapi
bronchial
epitheli
cell
central
particip
pathogenesi
airway
infl
ammatori
diseas
recent
found
could
regard
signal
pathway
demonstr
express
bronchial
epitheli
cell
primarili
regul
pathway
furthermor
b
isoform
import
express
wherea
g
littl
effect
result
reason
b
wide
distribut
wherea
g
enrich
leukocyt
howev
inhibit
pathway
could
partial
suppress
express
induc
bronchial
epitheli
cell
suggest
unidentifi
ed
signal
pathway
might
contribut
express
taken
togeth
result
provid
evid
might
play
import
role
airway
infl
ammatori
diseas
includ
copd
ptb
found
induc
express
chemokin
bronchial
epitheli
cell
via
activ
signal
pathway
elucid
interact
may
import
understand
treat
airway
infl
ammatori
diseas
bronchial
epitheli
cell
suggest
axi
may
particularli
import
develop
airway
infl
ammat
cytokin
includ
ifng
b
tnfa
also
describ
abl
induc
product
therefor
investig
whether
could
modul
product
bronchial
epitheli
cell
stimul
either
cytokin
ifng
cytokin
cytokin
proinfl
ammatori
cytokin
b
tnfa
famili
cytokin
demonstr
could
augment
product
bronchial
epitheli
cell
combin
infl
ammatori
cytokin
includ
ifng
b
tnfa
howev
could
activ
bronchial
epitheli
cell
produc
may
stimul
bronchial
epitheli
cell
cytokin
could
provid
integr
respons
activ
gene
transcript
protein
translat
via
transcript
factor
chromatin
phosphoryl
increas
nucleotid
synthesi
figur
effect
b
sirnaakt
express
cell
transfect
without
b
block
effect
valid
western
blot
block
effect
express
b
block
effect
express
b
c
block
effect
phosphoryl
akt
cell
transfect
b
sirnaakt
cell
cell
supernat
harvest
h
h
respect
stimul
ngml
level
gene
express
measur
revers
transcript
polymeras
chain
reaction
rtpcr
enzymelink
immunosorb
assay
elisa
e
level
protein
product
measur
rtpcr
elisa
result
express
arithmet
mean
sd
three
independ
experi
p
p
p
compar
group
denot
horizont
line
gadph
glyceraldehyd
dehydrogenas
see
figur
legend
expans
abbrevi
